Foxp3+ cells are running the show in patients with surgically resected nonsmall cell lung cancer

Eur Respir J. 2015 Dec;46(6):1541-3. doi: 10.1183/13993003.01595-2015.

¹ Gustave Roussy Cancer Campus, Villejuif, France Laboratory of Immune monitoring in Oncology UMS 3655 CNRS/US 23 INSERM Gustave Roussy Cancer Campus, Villejuif, France Cell Therapy Unit, Gustave Roussy Cancer Campus, Villejuif, France nathalie.chaput@gustaveroussy.fr.
² Gustave Roussy Cancer Campus, Villejuif, France Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France Drug Development Department, Gustave Roussy Cancer Campus, Villejuif, France.

No abstract available

Publication types